Immuron details Emerging Growth Conference notice

Immuron Limited submitted a Form 6-K as a foreign private issuer for October 2025.

Accepted by SEC EDGAR 10/20/2025 - 06:58 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Immuron Limited submitted a Form 6-K as a foreign private issuer for October 2025. The company furnished to U.S. investors a public notice it had released to the Australian Securities Exchange titled “Emerging Growth Conference”, attached as Exhibit 99.1.

The company states that this Form 6-K, including the exhibit, is being furnished rather than filed under the U.S. securities laws and will not be incorporated into other U.S. securities filings unless specifically referenced.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Immuron Limited (IMRN) report in this October 2025 Form 6-K?

Immuron Limited’s October 2025 Form 6-K furnishes a public notice previously released to the Australian Securities Exchange. The attached Exhibit 99.1 is titled “Emerging Growth Conference” and is provided to inform U.S. markets of the same information made available in Australia.

What is Exhibit 99.1 in Immuron Limited’s (IMRN) October 2025 Form 6-K?

Exhibit 99.1 is a copy of Immuron Limited’s public notice titled “Emerging Growth Conference,” originally published on the Australian Securities Exchange. The Form 6-K simply attaches this announcement so U.S. investors receive the same disclosure as investors in Immuron’s home market.

Is Immuron Limited’s (IMRN) Emerging Growth Conference notice considered filed under U.S. securities laws?

The Emerging Growth Conference notice is furnished, not filed, under U.S. securities laws. Immuron states the Form 6-K and its exhibit are not deemed filed for Exchange Act purposes and will only be incorporated into other U.S. filings if expressly referenced there.

Why did Immuron Limited (IMRN) furnish this Emerging Growth Conference notice on Form 6-K?

Immuron furnished the Emerging Growth Conference notice so U.S. investors can access the same information released on the Australian Securities Exchange. Using Form 6-K allows the company to distribute this announcement in the United States without treating it as a formally filed Exchange Act document.

Does this Immuron Limited (IMRN) Form 6-K include financial results or major transactions?

This Form 6-K does not present financial statements or major transaction details. It mainly transmits an Australian Securities Exchange public notice titled “Emerging Growth Conference,” attached as Exhibit 99.1, and clarifies the regulatory treatment of this information under U.S. securities law.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of October 2025

Commission File Number: 001-38104

IMMURON LIMITED

(Name of Registrant)

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒       Form 40-F ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐       No ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

IMMURON LIMITED

EXPLANATORY NOTE

Immuron Limited (the “Company”) published an announcement (the “Public Notice”) to the Australian Securities Exchange on October 20, 2025 titled:

-   Emerging Growth Conference

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

1

EXHIBITS

Exhibit Number		Description
99.1		Emerging Growth Conference

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IMMURON LIMITED
Date: October 20, 2025	By:	/s/ Phillip Hains
		Phillip Hains
		Company Secretary

3